Brazilian Competition Law and Access to Health in Brazil: Exploitative Pricing in the Pharmaceutical Sector

SOUTH CENTRE - 11 Jan, 2022
  • Tilis
  • by Tilis October 6, 2022

You May Also Like

Corporate purpose took a step backward this week

https://qz.com/ben-and-jerrys-israel-palestinian-territories-unilever-1849450069?utm_source=email&utm_medium=daily-brief&utm_content=

Tilis
Tilis

EU Consultation on the white paper on AI – a European approach – Google’s submission May 28, 2020

https://www.politico.eu/wp-content/uploads/2020/05/FINAL-Googles-submission-to-EC-AI-consultation.pdf?utm_source=POLITICO.EU&utm_campaign=8edd89390a-EMAIL_CAMPAIGN_2020_06_03_08_59&utm_medium=email&utm_term=0_10959edeb5-8edd89390a-190380769

Tilis
Tilis

After the DMA, the DSA and the New AI regulation: Mapping the Economic Consequences of and Responses to New Digital Regulations in Europe

https://ecipe.org/wp-content/uploads/2022/04/ECI_22_OccPaper_DMA-DSA-AI_03_2022_LY03.pdf

Tilis
Tilis